Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Phibro Animal Health Corporation Reports Second Quarter Results
February 6, 2019 4:25 PM ESTTEANECK, N.J., Feb. 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2018.
Highlights for the December 2018 quarter (compared to the December 2017 quarter)
Net sales of $218 million, an increase of $12 million, or 6%Net income of $15 million, an increase of $8 millionDiluted EPS of $0.36, an increase of $0.19Adjusted EBITDA of $32 million, a decline of $0.9 million, or 3%Adjusted diluted EPS of $0.41, a decrease of $0.03, or 7%COMMENTARY
... More